Dara-SVD vs. Dara-RVD

A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Diagnosed Multiple Myeloma

Near Add Your Location

  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients
Smilow Cancer Hospital
The Harold Leever Regional Cancer Center
Waterbury, CT
  • Accepting patients
Smilow Cancer Hospital
The Center for Cancer Care at Griffin Hospital
Derby, CT
  • Accepting patients
  • Accepting patients
Smilow Cancer Hospital
Saint Francis Hospital
Glastonbury, CT
  • Accepting patients
  • Accepting patients
Smilow Cancer Hospital
Shoreline Medical Center
Guilford, CT
  • Accepting patients
North Haven Medical Center
Yale-New Haven Hospital
North Haven, CT
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.